Investment Opportunities
Curated deal flow from the SoCal OASIS® innovation ecosystem
The SoCal OASIS® initiative supports the commercialization of high-impact technologies emerging from the University of California, Riverside and the broader Inland Southern California innovation ecosystem.
Below is a curated selection of life sciences companies currently raising capital. These opportunities span preclinical through pre-FDA stages and represent therapeutic innovation across neurology, ophthalmology, and metabolic disease.
Companies listed have been supported through the Office of Technology Partnerships and are actively engaging with investors aligned with translational science and clinical milestone-driven growth.
Featured Companies
Your Investment Liaison
Investor Inquiries
For access to company decks, data rooms, or introductions to founding teams, please contact:
Scott Brovsky
Associate Director, Regional Engagement
Entrepreneurial Proof-of-Concept and Innovation Center (EPIC)
scott.brovsky@ucr.edu
Confidential information provided for informational purposes only. This content does not constitute an offer to sell or a solicitation to buy securities. Investment opportunities are available only to qualified investors.